1. Home
  2. CNXC vs NBTX Comparison

CNXC vs NBTX Comparison

Compare CNXC & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Concentrix Corporation

CNXC

Concentrix Corporation

HOLD

Current Price

$28.04

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

BUY

Current Price

$21.06

Market Cap

1.7B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
CNXC
NBTX
Founded
1991
2003
Country
United States
France
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.7B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
CNXC
NBTX
Price
$28.04
$21.06
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$32.60
★ $54.00
AVG Volume (30 Days)
★ 1.7M
135.3K
Earning Date
09-29-2026
09-24-2026
Dividend Yield
★ 5.31%
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $9,825,771,000.00
N/A
Revenue This Year
$1.18
N/A
Revenue Next Year
N/A
$50.69
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 2.15
N/A
52 Week Low
$19.12
$14.78
52 Week High
$48.08
$57.14

Technical Indicators

Market Signals
Indicator
CNXC
NBTX
Relative Strength Index (RSI) 53.14 24.78
Support Level $24.98 $19.99
Resistance Level $30.75 $22.48
Average True Range (ATR) 1.55 1.46
MACD 0.22 -0.22
Stochastic Oscillator 74.22 3.69

Price Performance

Historical Comparison
CNXC
NBTX

About CNXC Concentrix Corporation

Concentrix Corp is a technology and services company. It designs, implements, and manages end-to-end solutions, including customer experience process optimization, technology development and design engineering, front- and back-office automation, analytics, and business transformation services. The company serves clients across multiple industry verticals, helping them manage customer engagement and operational processes throughout the customer lifecycle. The company operates in a single operating segment. It generates revenue through the provision of technology and services under contractual arrangements. Geographically, the company generates the maximum revenue from the Philippines and the rest from India, the United States, Great Britain, Germany, Canada and Other countries.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: